- Home
- SBFM vs MGIC Comparison
SBFM vs MGIC Comparison
Compare SBFM & MGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- MGIC
- Stock Information
- Founded
- SBFM 2006
- MGIC 1983
- Country
- SBFM United States
- MGIC Israel
- Employees
- SBFM N/A
- MGIC N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- MGIC Computer Software: Prepackaged Software
- Sector
- SBFM Health Care
- MGIC Technology
- Exchange
- SBFM Nasdaq
- MGIC Nasdaq
- Market Cap
- SBFM 6.7M
- MGIC 788.0M
- IPO Year
- SBFM N/A
- MGIC 1991
- Fundamental
- Price
- SBFM $1.51
- MGIC $20.80
- Analyst Decision
- SBFM Strong Buy
- MGIC Buy
- Analyst Count
- SBFM 1
- MGIC 2
- Target Price
- SBFM $15.00
- MGIC $16.00
- AVG Volume (30 Days)
- SBFM 192.4K
- MGIC 95.6K
- Earning Date
- SBFM 08-15-2025
- MGIC 08-13-2025
- Dividend Yield
- SBFM N/A
- MGIC 2.70%
- EPS Growth
- SBFM N/A
- MGIC 1.33
- EPS
- SBFM N/A
- MGIC 0.76
- Revenue
- SBFM $36,234,578.00
- MGIC $569,136,000.00
- Revenue This Year
- SBFM $192.48
- MGIC $7.53
- Revenue Next Year
- SBFM N/A
- MGIC $8.96
- P/E Ratio
- SBFM N/A
- MGIC $27.28
- Revenue Growth
- SBFM 35.51
- MGIC 6.37
- 52 Week Low
- SBFM $1.17
- MGIC $9.64
- 52 Week High
- SBFM $6.99
- MGIC $22.00
- Technical
- Relative Strength Index (RSI)
- SBFM 49.86
- MGIC 70.18
- Support Level
- SBFM $1.43
- MGIC $20.50
- Resistance Level
- SBFM $1.61
- MGIC $22.00
- Average True Range (ATR)
- SBFM 0.12
- MGIC 0.55
- MACD
- SBFM 0.00
- MGIC 0.09
- Stochastic Oscillator
- SBFM 32.78
- MGIC 75.45
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.